NIFEDIPINE ER 60 MG TABLET
For 30 tablets
Pharmacies pay
$4.88 – $5.04 filed
30 × $0.16266 to $0.16809 per EA (the 21 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$10.50 filed
30 × $0.34989 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.1× – 2.2× estimated
Medicare paid between 2.1× and 2.2× what pharmacies pay, depending on the NDC.
Part D averages every strength and form sold under “Nifedipine ER” / “Nifedipine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$10.61 – $10.80 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
NIFEDIPINE ER 60 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as nifedipine, under the trade name “Nifedipine ER”.
FDA gives its dosage form as “tablet, film coated, extended release” and “tablet, extended release” and its route as oral.
FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Upsher-Smith Laboratories, LLC and AvPAK.
FDA’s Established Pharmacologic Class for it is Dihydropyridine Calcium Channel Blocker.
The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 17 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.88 – $5.04 for 30 tablets, depending on the NDC ($0.16266 to $0.16809 per EA), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 9 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Ingenus Pharmaceuticals, LLC | 3 | $0.16266 to $0.16809 per EA filed |
| Lannett Company, Inc. | 3 | $0.16809 per EA filed |
| American Health Packaging | 2 | $0.16809 per EA filed |
| Ascend Laboratories, LLC | 2 | $0.16809 per EA filed |
| Major Pharmaceuticals | 2 | $0.16809 per EA filed |
| Upsher-Smith Laboratories, LLC | 2 | $0.16809 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.16266 per EA filed |
| AvPAK | 1 | $0.16809 per EA filed |
| Chartwell RX, LLC | 1 | $0.16809 per EA filed |
| Not listed as a package in the FDA directory | 4 | $0.16809 per EA filed |
All 21 NDCs, with labeler and price
- 00904-7081-06 · Major Pharmaceuticals · $0.16809 per EA · eff. 2026-09-23 filed
- 00904-7081-61 · Major Pharmaceuticals · $0.16809 per EA · eff. 2026-09-23 filed
- 24979-0010-01 · Upsher-Smith Laboratories, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 24979-0010-12 · Upsher-Smith Laboratories, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 50268-0598-11 · not listed as a package in the FDA directory · $0.16809 per EA · eff. 2026-09-23 filed
- 50268-0598-15 · AvPAK · $0.16809 per EA · eff. 2026-09-23 filed
- 50742-0261-01 · Ingenus Pharmaceuticals, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 50742-0261-03 · Ingenus Pharmaceuticals, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 50742-0621-01 · Ingenus Pharmaceuticals, LLC · $0.16266 per EA · eff. 2026-09-23 filed
- 59651-0296-01 · Aurobindo Pharma Limited · $0.16266 per EA · eff. 2026-09-23 filed
- 62135-0522-90 · Chartwell RX, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 62175-0261-37 · Lannett Company, Inc. · $0.16809 per EA · eff. 2026-09-23 filed
- 62175-0261-46 · Lannett Company, Inc. · $0.16809 per EA · eff. 2026-09-23 filed
- 62175-0261-55 · Lannett Company, Inc. · $0.16809 per EA · eff. 2026-09-23 filed
- 67877-0758-01 · Ascend Laboratories, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 67877-0758-58 · Ascend Laboratories, LLC · $0.16809 per EA · eff. 2026-09-23 filed
- 68084-0598-01 · American Health Packaging · $0.16809 per EA · eff. 2026-09-23 filed
- 68084-0598-11 · not listed as a package in the FDA directory · $0.16809 per EA · eff. 2026-09-23 filed
- 68084-0598-65 · American Health Packaging · $0.16809 per EA · eff. 2026-09-23 filed
- 68645-0513-54 · not listed as a package in the FDA directory · $0.16809 per EA · eff. 2026-09-23 filed
- 68645-0604-54 · not listed as a package in the FDA directory · $0.16809 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share the FDA nonproprietary name nifedipine with NIFEDIPINE ER 60 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| NIFEDIPINE 10 MG CAPSULE | $0.25672 per EA filed | $0.55648 per EA filed |
| NIFEDIPINE 20 MG CAPSULE | $0.68559 per EA filed | $0.55648 per EA filed |
| NIFEDIPINE ER 30 MG TABLET | $0.11663 to $0.13006 per EA filed | $0.34989 per EA filed |
| NIFEDIPINE ER 60 MG TABLET this page | $0.16266 to $0.16809 per EA filed | $0.34989 per EA filed |
| NIFEDIPINE ER 90 MG TABLET | $0.25884 to $0.26915 per EA filed | $0.34989 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 21 NDCs’ NADAC prices is $0.16809 per EA filed.
Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 54 have a higher middle NADAC price and 13 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $10.50 for 30 tablets, at an average of $0.34989 per EA in 2024 (2024-01-01 to 2024-12-31) for “Nifedipine ER” and “Nifedipine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 3,845,740 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.16266 to $0.16809 per EA for this product, depending on the NDC.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for NIFEDIPINE ER 60 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nifedipine ER / Nifedipine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- AMLODIPINE BESYLATE 10 MG TAB
- AMLODIPINE-BENAZEPRIL 10-20 MG
- AMLODIPINE-VALSARTAN 10-160 MG
- AMLODIPINE-OLMESARTAN 10-20 MG
- FELODIPINE ER 10 MG TABLET